Titre:
  • A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging
Auteur:Jager, Agnes; de Vries, E.G.E.; Der Houven Van Oordt, Willemien Menke C.W.M.V.; Neven, Patrick; Venema, Clasina C.M.; Glaudemans, Andor A.W.J.M.; Wang, Yamei; Bagley, Rebecca R.G.; Conlan, Maureen M.G.; Aftimos, Philippe
Informations sur la publication:Breast cancer research, 22, 1, 97
Statut de publication:Publié, 2020-09
Sujet CREF:Cancérologie
Mots-clés:16α-18F-fluoro-17β-estradiol (FES)
Advanced breast cancer
Elacestrant
Endocrine therapy
Estrogen receptor
Hormonal therapy
Metastatic breast cancer
Positron emission tomography (PET)
RAD1901
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1465-5411
info:doi/10.1186/s13058-020-01333-3
info:scp/85090818904
info:pmid/32912274